116 First-in-human clinical trial with SPL84, an antisense oligonucleotide for treatment of people with cystic fibrosis with the 3849 +10 Kb C - > T mutation
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Y. Caraco, M. Wanounou, L. Friedman, A. Cohen, G. Hart, E. Kerem Tags: CLINICAL TRIALS & OUTCOME MEASURES Source Type: research